Palatin Technologies Inc (PTN)
1.99
-0.12
(-5.69%)
USD |
NYAM |
May 06, 15:09
Palatin Technologies Revenue (Annual): 4.854M for June 30, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
June 30, 2023 | 4.854M |
June 30, 2022 | 1.468M |
June 30, 2021 | -0.1886M |
June 30, 2020 | 0.118M |
June 30, 2019 | 60.30M |
June 30, 2018 | 67.13M |
June 30, 2017 | 44.72M |
June 30, 2016 | |
June 30, 2015 | 12.95M |
June 30, 2014 | |
June 30, 2013 | 0.0104M |
June 30, 2012 | 0.0737M |
June 30, 2011 | 1.476M |
June 30, 2010 | 14.18M |
Date | Value |
---|---|
June 30, 2009 | 11.35M |
June 30, 2008 | 11.48M |
June 30, 2007 | 14.41M |
June 30, 2006 | 19.75M |
June 30, 2005 | 17.96M |
June 30, 2004 | 2.315M |
June 30, 2003 | 1.27M |
June 30, 2002 | 0.2814M |
June 30, 2001 | 1.788M |
June 30, 2000 | 5.117M |
June 30, 1999 | 0.61M |
June 30, 1998 | 0.034M |
June 30, 1997 | 0.70M |
June 30, 1996 | 0.0245M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
-0.1886M
Minimum
2021
60.30M
Maximum
2019
13.31M
Average
1.468M
Median
2022
Revenue (Annual) Benchmarks
Oragenics Inc | -- |
Outset Medical Inc | 130.38M |
Ligand Pharmaceuticals Inc | 131.31M |
Galectin Therapeutics Inc | -- |
ADMA Biologics Inc | 258.22M |